Juice Co. – FDA Warning Letter, Feb 1, 2026

The U.S. Food and Drug Administration (FDA) issued a Warning Letter dated February 27, 2026, to idripejuice.com, citing significant violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act). Following a review of their website, the FDA"s Center for Tobacco Products determined that the company was unlawfully selling Electronic Nicotine Delivery System (ENDS) products, specifically "GiMi 8500 Disposable 5% Pineapple Breeze," to individuals under 21 years of age. An FDA investigation confirmed this by an underage person successfully purchasing products from the website. This practice violates the FD&C Act, which prohibits retailers from selling tobacco products to anyone younger than 21, thus rendering the sold products "misbranded." Idripejuice.com is mandated to promptly address these violations and ensure all its tobacco products and related marketing comply with the FD&C Act and FDA regulations. The company must submit a written response to the FDA within 15 working days, detailing corrective actions, including dates when violative sales, advertising, or distribution ceased, and outlining a plan for maintaining future compliance. Failure to comply may lead to further regulatory actions like civil money penalties, product seizure, or injunctions.